This website uses cookies to ensure you get the best experience on our website.
Accept Cookies
Learn More
Green Journals
Home
Hijacked
Contact Us
More
Simulation
Green Recruitments
About Us
Blog
Login
Register
English
English
Français
العربية
Journal Report
PharmacoEconomics
Download PDF
Print
Journal Information
Journal Title
PharmacoEconomics
Publisher
Springer International Publishing
ISSN
1170-7690
E-ISSN
1179-2027
Database
ABDC
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year
A+
A
B
C
2026
✓
✓
2025
✓
✓
2024
✓
✓
2023
✓
✓
2021/2022
✓
✓
2020
✓
✓
2019
✓
✓
✓
2018
✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Modelling Carer Quality-Adjusted Life-Years Into Economic Evaluations: An Evidence Assessment Group Perspective
Giovany Orozco-Leal, Louise Tanner, Eugenie Evelynne Johnson et al.
2026-10-26
DOI:
10.1007/s40273-026-01685-2
Measuring the Health of Young Children
Daniel M. Hausman
2026-10-25
DOI:
10.1007/s40273-026-01675-4
Beyond Traditional Cost-Effectiveness Analysis: Operationalizing the Equivalent Income Approach for Equity-Sensitive Health Technology Assessment
Pauline Chauvin, Clémence Thébaut
2026-10-23
DOI:
10.1007/s40273-026-01676-3
Patient-Centered Value Elements in the Economic Evaluation of Chronic Obstructive Pulmonary Disease (COPD): A Targeted Review of Cost-Effectiveness Analyses
Nabin Poudel, Leah Lodise, Jiwon Oh et al.
2026-10-22
DOI:
10.1007/s40273-026-01662-9
The Opportunity Cost of Funding High-Cost Biologics in the Context of Inequitable Access to the Fundamentals of Care: An External Assessment Group Perspective
Julia Whitehall, Louise Tanner, Nawaraj Bhattarai et al.
2026-10-15
DOI:
10.1007/s40273-026-01678-1
Methodological Challenges and Preferred Approaches for the Economic Evaluation of CAR T Therapies: Evidence Review and Expert Consensus from NICE Appraisals
Mehdi Yousefi, Amin Mehrabian, Maeve A. O’Reilly et al.
2026-10-9
DOI:
10.1007/s40273-026-01673-6
Waiting for Trial Evidence or Using Real-World Evidence: Trade-Offs for Coverage with Evidence Development
Boshen Jiao, Yizhi Liang, Liyuan Tao et al.
2026-10-9
DOI:
10.1007/s40273-026-01668-3
Correction: Comparing User‑Written Codes for Performing Economic Evaluations in Stata
Bradley Barker-Jones, Patricia Navvuga, Petra Baji et al.
2026-10-6
Vol. 44
Issue 11
Pages 1427-1427
DOI:
10.1007/s40273-026-01663-8
Methods in Systematic Reviews of Health Economic Evaluations in Submissions to Health Technology Assessment Agencies: How Systematic Are They, and Does This Matter?
Chris Bartlett, Rachael McCool, Matthew Taylor
2026-10-6
DOI:
10.1007/s40273-026-01672-7
Meta-Analysis of Incremental Net Benefit from Trial-Based Health Economic Evaluations in R: A Tutorial
Romain Jonathan Collet, Johanna Maria van Dongen, Oraluck Pattanaprateep et al.
2026-9-30
DOI:
10.1007/s40273-026-01665-6
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 30, 2026 03:07